# A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

> **NCT00036439** · PHASE3 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 364 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00036439
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00036439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00036439, "A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00036439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*